Who we are

Zafgen (Nasdaq:ZFGN) is a clinical-stage biopharmaceutical company developing potentially transformative therapies for patients affected by a range of metabolic diseases.

At the core of Zafgen are dedicated people whose resolve, compassion, collaborative mindset and enthusiasm for solving challenges is unwavering. We are driven by a sense of purpose to meet the unique needs of patients affected by a range of complex metabolic diseases who are depending on us to deliver first-in-class therapies that have the potential to significantly impact their lives.

In their own words, our team shares the Zafgen difference – what inspires them, what drives our work and their hopes for people impacted by the serious diseases we are determined to address.

Our Approach

Learn more about our team’s approach to advance insight-driven MetAP2 therapeutics